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Because the sugar moieties of natural products are
primarily O-linked, the hydrolytic sensitivity of the
glycosidic linkage limits their therapeutic application.
Onepotential solution to thisproblem is to replace the
labile O-glycosidic bond with an enzymatically and
chemically stable C-glycosidic bond. In this study,
computational analysis of the O-glycosyltransferase
LanGT2 and the C-glycosyltransferase UrdGT2 was
used to predict the changes necessary to switch the
O-glycosylating enzyme to a C-glycosyltransferase.
By screening rationally designed LanGT2 mutants
a number of LanGT2variantswithC-glycosyltransfer-
ase activity were identified. One variant, having 10
amino acid substitutions, revealed the primary re-
gion that determines O- versus C-glycosylation. By
modeling the active site of this mutant and probing
the role of active site residues with alanine substitu-
tions, this work also illuminates the mechanistic
features of O- and C-glycosylation.
INTRODUCTION
The field of protein engineering is steadily developing new tech-
niques to create enzymes and proteins with desired features
(Schmid et al., 2001). Improving enzyme characteristics such
as substrate specificity, stereo- and regioselectivity, ther-
mostability, solvent tolerance, or the enhancement of catalytic
efficiency has been successfully applied to many enzymes
(Petrounia and Arnold, 2000). Part of this success is due to rapid
advances in the creation of large protein libraries through
random mutagenesis techniques (particularly with polymerase
chain reaction [PCR]) along with efficient screening or selection
methods to find proteins with desired features (Williams et al.,
2008a; Reidhaar-Olson and Sauer, 1988; Turner, 2009). Like-
wise, rational design in which targeted mutations are guided
by techniques like crystallography and computational modeling,
has also proven to be a successful, and more straightforward,520 Chemistry & Biology 18, 520–530, April 22, 2011 ª2011 Elsevierapproach for generating desired properties in proteins (Love,
2010; Hohne et al., 2010).
Glycosyltransferases (GTs) are a key class of enzyme involved
in the biosynthesis and diversification of many natural products
(Williams and Thorson, 2008; Thibodeaux et al., 2007). With re-
gio- and stereospecific control these enzymes transfer a wide
array of glycosyl moieties onto other sugars or natural product
aglycons of polyketide or nonribosomal polypeptide origin
(Luzhetskyy et al., 2008; Olano et al., 2010). Often this reaction
converts a nonbioactive intermediate into a drug (Weymouth-
Wilson, 1997; Heddle and Maxwell, 2002). In the field known
as combinatorial biosynthesis (Walsh, 2002), GTs and other
so-called post-tailoring enzymes are introduced or deleted
within a biosynthetic pathway to produce new compounds
(Walsh et al., 2001). Although this approach can be very valuable
to gain structural diversity, its application is often limited by the
native specificity of an enzyme. The rational design of new
tailoring enzymes may be one solution for expanding these
boundaries. In addition to the physiologically relevant properties,
the stability of a pharmaceutical compound is also a key feature
that must be considered. This is a particularly crucial issue
concerning glycosylated compounds. For instance, although
O-glycosides are acid-sensitive, sugar moieties attached by
C-glycosidic bonds are stable toward chemical hydrolysis. This
fact offers interesting biological applications because C-glyco-
sides may mimic the bioactivity of the corresponding O-glyco-
sides, but offer considerably more resistance to degradation
(Weatherman, et al., 1996). In this context the GTs present
a significant opportunity for protein engineering as they catalyze
the attachment of a sugar to a sugar-acceptor (Davis, 2007). In
general glycosyl transfer occurs from a NDP-activated sugar to
the hydroxyl group of an acceptor (Unligil and Rini, 2000). Conse-
quently, GTs divide into two mechanistic classes of glycosyl
transfer, inverting and retaining, according to the anomeric
configuration of the sugar before and after glycosylation. Both
retaining and inverting GTs require general base catalysis to
increase the reactivity of the acceptor hydroxyl group. Whereas
the retaining GTs likely follow a double displacementmechanism
to achieve retention of anomeric configuration, the inverting
O-GTs follow what is essentially a single step SN2 reaction,
wherein an acceptor hydroxyl group is deprotonated to directly
attack the anomeric C1 of theNDP-sugar to form anO-glycosidicLtd All rights reserved
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nucleoside diphosphate that functions as a good leaving-
group (Unligil and Rini, 2000). With steadily increasing knowl-
edge about GT structures and mechanisms, these enzymes
have also been subjected to rational design to obtain desired
features (Williams et al., 2008b).
Namely, sequence and structural-guided mutagenesis has
been successfully applied to several bacterial natural product
GTs (e.g., OleD, GtfE, KanF, ElmGT) (Williams et al., 2007;
Ramos et al., 2009; Park et al., 2009; Truman et al., 2009).
Next to others, these articles impressively document how modi-
fied GTs expand the diversification of therapeutically important
compounds. Generally, the engineering approaches weremainly
focused on modifying the enzyme to incorporate other sugars.
However, in other studies GTs were designed with new regiose-
lectivities, including an example from our lab involving the urda-
mycin olivosyltransferase from Streptomyces fradiae Tu¨2717,
UrdGT1b. Whereas wild-type UrdGT1b transfers D-olivose to
the C4 hydroxyl of L-rhodinose during the biosynthesis of urda-
mycin, an engineered derivative was created that catalyzed
transfer to the C4 hydroxyl of the nearby D-olivose moiety,
yielding in an unusual branched oligosaccharide (Hoffmeister
et al., 2002). Furthermore, in 2009 we were able to convert the
Streptomyces globisporus LndGT1 from a GT that natively cata-
lyzes the attachment of a single sugar during landomycin E
biosynthesis toward an iteratively acting enzyme (Krauth et al.,
2009). This modification is of special interest as an elongated
sugar chain is believed to enable better penetration of amolecule
through cell membranes (Weymouth-Wilson, 1997).
In this study, we present the process of engineering the
O-glycosylating enzyme LanGT2 from Streptomyces cyanogenus
S136 to a C-glycosylating enzyme. LanGT2 catalyzes formation
of an O-glycosidic bond in what is the initial glycosylation
step in the biosynthesis of the anticancer agent landomycin A
(Figure 1A) (Luzhetskyy et al., 2005; Shaaban et al., 2011). The
nucleophilic site for the wild-type glycosyl transfer reaction is
the hydroxyl group of a hydroxyanthroquinone ring system. We
hypothesized that LanGT2 could be converted to a C-glycosylat-
ing enzyme through redesign of the active site to achieve
glycosyl transfer to the carbon ortho to the acceptor hydroxyl
moiety. We also hypothesized that general base activation of
the phenolic oxygen would afford carbanionic character to the
ortho-carbon, thereby providing an opportunity for nucleophilic
attack of this carbon on the anomeric position of the donor sugar
to form the desired aryl-C-glycoside.
The exact mechanism of C-glycosidic bond forming GTs is not
well understood and can primarily be suggested based on
knowledge from general aromatic substitution chemistry. Two
mechanisms, the O- to C-glycosyl rearrangement and a Frie-
del-Crafts-like mechanism, have been proposed for C-GTs
(Bililign et al., 2004; Durr et al., 2004). Early studies by our group
on UrdGT2, the C-glycoside forming GT from the Urdamycin A
producer S. fradiae Tu¨2717 (Figure 1A), revealed this enzyme to
be highly promiscuous with respect to acceptor and sugar donor
specificity. However, in all cases, UrdGT2 was regiospecific for
glycosyl transfer to the ortho-position of hydroxyanthroquinone
acceptors. This was even the case for 1,2-dihydroxyanthraqui-
none (alizarin), whereby UrdGT2 transferred D-olivose to the
ortho-hydroxyl, thereby forming an O-glycoside. The ability ofChemistry & Biology 18,UrdGT2 to form O- and C-glycosidic bonds ortho to the phenolic
oxygen of the acceptor strongly suggests a direct Fiedel-Crafts-
like alkylation as the mechanism rather than an O- to C-rear-
rangement (Durr et al., 2004; Baig et al., 2006; Faust et al.,
2000; Hoffmeister et al., 2000, 2001, 2003). In 2006, the X-ray
crystal structure of UrdGT2 was published, but unfortunately
attempts to obtain a complex with glycosyl donor and acceptor
substrates, which would have provided more concrete insights
into the reaction mechanism, were unsuccessful (Mittler et al.,
2007). Nevertheless, considerable structural information exists
for related natural product O-GTs, such as GtfA (Protein Data
Bank [PDB] code 1PN3), GtfD (PDB code 1RRV), OleD (PDB
code 2IYF), and OleI (PDB code 2IYA), all of which had been
crystallized with substrates. Moreover, the overall topologies
and active sites of these enzymes are highly conserved (Mulichak
et al., 2003, 2004; Bolam et al., 2007). This provides important
information about the mechanisms and substrate specificities
of the GT-B superfamily, to which most natural product GTs
belong.
The O-glycosyltransferase LanGT2, the target of our study,
accepts the same sugar-donor and a similar sugar-acceptor as
the C-GT UrdGT2 (Figure 1A) (Luzhetskyy et al., 2005; Zhu
et al., 2005). Additionally, the primary sequences of LanGT2
and UrdGT2 (373 and 378 amino acids, respectively) share
53% sequence identity (Figure 1B). The high sequence similarity
shared by these enzymes, along with the observed flexibility of
UrdGT2 in catalyzing C- and O-glycosidic bonds, suggested
that it may be possible to use specific mutations to transform
LanGT2 from an O-GT to a C-GT. An in vivo test system for this
approach, the mutant S. cyanogenus DlanGT2, was available in
our laboratory. Expression of urdGT2 in this mutant results in
the production of the C-glycoside 9-C-D-olivosyltetrangulol
(Luzhetskyy et al., 2005). In contrast, expression of lanGT2 in
this mutant leads to the production of O-glycoside 8-O-D-olivo-
syllandomycinone (Luzhetskyy et al., 2005, Zhu et al., 2007) (Fig-
ure 2). Following a sequence and structural-based mutagenesis
approach we constructed in total 106 variants of LanGT2 and
tested for C- or O-glycosylating activity.
The differences in sequence of LanGT2 and UrdGT2 are
distributed throughout the polypeptide chains, resulting in
uncertain predictions about regions governing the substrate
specificity or functional relevance. Despite the lesser extent of
sequence identity of LanGT2 to the natural product GTs OleD
(18%), OleI (20%), GtfA (18%), and, GtfD (17%), the structures
of these enzymes provided a basis for the computational protein
modeling experiments described in this study and ultimately the
successful creation of a C-glycosylating-LanGT2.
RESULTS
Construction of LanGT2-UrdGT2 Chimeras
To determine which sequence regions of UrdGT2 were respon-
sible for the C-glycosylating function, two routes in parallel
were attempted. The first used restriction enzyme digests and
ligation reactions to assemble a small library of urdGT2-lanGT2
chimeric genes. Sequence alignment revealed specific restric-
tion sites convenient for constructing the hybrids (Figure 1B).
Additional restriction sites were introduced by PCR-based
mutagenesis (see Supplemental Experimental Procedures520–530, April 22, 2011 ª2011 Elsevier Ltd All rights reserved 521
Figure 1. Functions of the Glycosyltransferases LanGT2 and UrdGT2, a Structural-Based Sequence Alignment and a LanGT2 Ternary Model
Illustrating the Protein Regions Investigated by Targeted-Amino Acid Replacement Studies
(A) During landomycin A biosynthesis the O-glycosyltransferase LanGT2 from Streptomyces cyanogenus S136 catalyzes an O-glycosidic bond (red) between
D-olivose and the corresponding landomyin aglycon. The C-glycosyltransferase UrdGT2 from Streptomyces fradiae Tu¨2717 attaches by a C-glycosidic bond
(blue) the same deoxy sugar toward a very similar angucycline named UWM6.
(B) The secondary structure is derived from UrdGT2 crystal structure (Protein Data Bank [PDB] code 2P6P). Protein regions of homology between LanGT2 with
UrdGT2 used for substitution studies are presented in brackets and segmented in colored blocks: 1 (dark green); 2 (marine blue); 3 (purple); 4 (cyan); 5 (orange);
6 (olive); and 7 (gray) plus a (brown), b (salmon), and c (red). Residues replacedwith alanine to probe their role in O- and C- glycosylation are indicated with arrows.
The location of restriction sites utilized for creating LanGT2-UrdGT2 hybrids are indicated.
(C) Homology model of LanGT2 with TDP-D-olivose and 11-deoxy-landomycinone based on the modeled UrdGT2 ternary complex described in Mittler et al.
(2007). The LanGT2 protein regions that were substituted with homologous sites from UrdGT2 are highlighted with the some colors as presented in the sequence
alignment: region 1 (Ser52–Met64) in dark green, region 2 (Met63–Thr76) in marine blue, region 3 (Val132–Thr144) in purple, region 4 (Asp150–Asp162) in cyan,
region 5 (Leu221–Gly228) in orange, region 6 (Ser303–Ala311) in olive, block a (Asp30–Val36) in brown, block b (Glu37–Ala50) in salmon, and block c (Leu51–Y61)
in red.
See also Figures S1 and S2.
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Figure 2. In Vivo Test System
S. cyanogenus DlanGT2 served as the expression host.
Whereas the mutant itself produces tetrangulol, expres-
sion of LanGT2, UrdGT2, or a C-glycosylating LanGT2
variant, the derivatives 8-O-D-olivosyl-11-deoxy-land-
omycinone or 9-C-D-olivosyltetrangulol are produced.
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C-terminal halves of each enzyme were ligated to generate 12
different lanGT2-urdGT2 chimeras (lanGT2.h1 to lanGT2.h12)
(Table S1). The second approach utilized site-directed mutagen-
esis guided by sequence and structure analysis of LanGT2 with
UrdGT2 and other natural product GTs.
Generating LanGT2-Variants with UrdGT2 Loops
Sequence alignments of UrdGT2 and LanGT2 with the GTs OleI,
OleD,GtfA, andGtfD (FigureS1) revealed twoprotein regions that
are exceptionally variable. These regions can be localized to the
N3- and N5-loops, both of which link a b sheet to an a helix. Due
to the observed sequence variability, we presumed that these
regions may in part govern substrate specificity either by direct
or second sphere derived ligand interactions. X-ray crystal struc-
tures of the cocrystallized natural product GTs also show that
these loops line the sugar acceptor pockets (Unligil and Rini,
2000). Additionally, in GTs crystallized without substrates, the
electron density representing these regions were poorly resolved
(Unligil and Rini, 2000; Mittler et al., 2007). This is indicative of
conformational flexibility and further suggests the relevance of
these loops in sculpting the sugar acceptor pocket. The very
similar topology of GTs within the GT-B family, plus the high
sequence variability in N3- and N5-loops, prompted the idea
that enzyme specificity could be altered simply by swapping
the loop regions. The fact that the same sugar donor and very
similar acceptor molecules are recognized by LanGT2 and
UrdGT2 suggested that LanGT2 could be switched to an
UrdGT2-like C-glycosylating enzyme mainly by redesigning the
loop regions of the acceptor binding site. To experimentally eval-
uate this idea the loop regions assumed to govern specificity in
the LanGT2 acceptor pocket were substituted with the corre-
spondingUrdGT2 loop regions. Toavoid a structural clash arising
from replacing relatively long stretches of sequence, the N3- and
N5-loops were subdivided into blocks 1 + 2 and 3 + 4, respec-
tively (Figure 1B). In addition, the structure of UrdGT2 revealed
three residues (Glu66, Glu71, or Glu224) that could serve as
a general base to increase the phenolate character of the
acceptor and trigger the C-glycosylation reaction. As presentedChemistry & Biology 18, 520–530, April 22by Mittler et al. (2007) the modeled UrdGT2
enzyme-ligand complex confirmed the close
contact of Glu224 to both the sugar donor and
acceptor molecules. Interestingly, as shown by
the LanGT2-UrdGT2 sequence alignment,
LanGT2 displays a gap of three amino acids
where this residue is expected (223KES225 in
UrdGT2). To prove if this region is relevant for
C-GT functionality, LanGT2 residues within
the region Leu221–Gly228 (block 5) were
substituted with the corresponding UrdGT2
amino acids (Val221–Asp231). By applyinga PCR megaprimer method (Ho et al., 1989), 30 different com-
binations of the UrdGT2 protein regions 1–5 (Figure 1B) were
substituted into LanGT2, resulting in mutants 13–43 (Table S2).
Functional Screening of the LanGT2-UrdGT2 Hybrids
The 12 lanGT2-urdGT2 chimeras and 30 PCR derived lanGT2
point mutants were cloned into the Escherichia coli-
Streptomyces shuttle vector pUWL-oriT. The expected changes
were verified by DNA sequencing. The lanGT2 mutants were
then heterologously expressed in S. cyanogenus DlanGT2 under
the control of the ermE* promotor on the vector. After cultivating
the complimented strain under producing conditions, the
secondary metabolites were extracted and analyzed by
HPLC-MS. Four weakly active LanGT2 variants were identified
from this library. The mutants LanGT2.4, LanGT2.5, and
LanGT2.45 all formed 8-O-D-olivosyllandomycinone and thus
still retained the wild-type O-glycosylating activity (Table S2).
However, careful MS analysis of the extract afforded by the
LanGT2.1 mutant revealed a minute quantity of the C-glycoside
product. In this variant residues 52–64 derived from UrdGT2
appear to contribute to the desired C-glycosylating function
(Table S2).
A very similar result was obtained by investigating the 12
LanGT2-UrdGT2 chimeras. Most of these mutants were likely
unstable or inactive, as no conversion could be detected.
However, the variant LanGT2.h1, in which the N-terminal 62
amino acid residues are derived from UrdGT2, specifically
produced the C-glycoside product with 17% of the UrdGT2
conversion factor (Table S1). The product 9-C-D-olivosyltetran-
gulol displayed the typical ultraviolet (UV)-visible spectrum of
tetrangulol, whereas HPLC-MS analysis revealed the expected
pseudo-molecular ion (433.1 [M-H]) representing the mass of
D-olivose attached to tetrangulol (Luzhetskyy et al., 2005) (Fig-
ure 3B). The structures of the metabolites 8-O-D-olivosyllando-
mycinone and 9-C-D-olivosyltetrangulol were characterized
previously by NMR and MS analysis (Luzhetskyy et al., 2005;
Zhu et al., 2007). For instance Luzhetskyy et al. heterologously
expressed the C-GT UrdGT2 in S. cyanogenus DlanGT2 and
observed a product with the analogous retention time, mass, 2011 ª2011 Elsevier Ltd All rights reserved 523
Figure 3. HPLC-MS/MS Analysis of the O- and C-Glycosides Produced by LanGT2, UrdGT2, and Selected C-Glycosylating LanGT2 Variants
Reversed phase HPLC-MS/MS analysis of the crude extracts isolated from S. cyanogenus DlanGT2 after expressing LanGT2.c, LanGT2.h1, LanGT2.S8A_c,
LanGT2.S8A_a_c, LanGT2, or UrdGT2. LanGT2 and UrdGT2 were used as positive controls.
(A) LanGT2 produces the O-glycoside 8-O-D-olivosyl-11-deoxy-landomycinone that has a retention time of 16min and can be detected by absorbance at 254 nm
as well as selective ion monitoring by MS (negative ion mode, m/z = 451.1). Absorbance and MS chromatograms are shown at the far left. Only the wild-type
LanGT2 produces the O-glycoside product at detectable levels. The corresponding MS/MS fragmentation ion spectrum for 8-O-D-olivosyl-11-deoxy-land-
omycinone (molecular ion marked with a diamond) is shown along with the structures of the corresponding putative fragment ions.
(B) The enzymes LanGT2.c, LanGT2.h1, LanGT2.S8A_c, LanGT2.S8A_a_c, and UrdGT2 produce the C-glycoside 9-C-D-olivosyltetrangulol that elutes at
20.8 min and can be detected by absorbance at 254 nm and selective ion monitoring for the molecular ion m/z = 433.1. The MS/MS fragmentation pattern for the
pseudo-molecular ion 433.1 [M-H] (marked with a diamond), derived from the UrdGT2 and C-glycosylating LanGT2 derivatives product, differs strongly from
that for the O-glycoside product of LanGT2. The suggested structures of the fragment ions are shown.
See also Figure S3.
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by the LanGT2 derivative LanGT2.h1.
In addition to the distinct differences in absorbance spectra
and masses of the O- and C- glycosylated tetrangulol deriva-
tives, HPLC-MS/MS analysis could also demonstrate the
presence of the C-glycosidic bond. This is because gas phase
fragmentation of the much stronger C-glycosidic bond requires
higher collision energies than that required for O-glycosides
(Abad-Garcia et al., 2008). Crude extracts isolated from
S. cyanogenus DlanGT2 expressing LanGT2, UrdGT2, and
selected C-glycosylating LanGT2-derivatives were analyzed by
LC-MS/MS. For the glycosylation product formed by the
C-GTs the fragmentation pattern for the pseudo-molecular ion
433.1 [M-H] was extracted. As this ion represents 9-C-D-olivo-
syltetrangulol, no fragment corresponding to the deglycosylated
state could be detected. In contrast, on fragmentation of the
LanGT2 product ion 451.1 [M-H], the expected deglycosylated
landomycinone ion m/z = 321.1 was clearly observed (Figure 3;
Figure S3).
Additional Refinement of N-Terminal Residues
to Improve C-Glycosylation
The activity shown by LanGT2.1 and LanGT2.h1 motivated us
to investigate the specific sites within the N-terminal 62 amino
acids that are relevant for the C-glycosylating activity. For this
purpose the most variable sequence regions between LanGT2
and UrdGT2 (positions 30–62) were divided into blocks a, b,
and c (Figure 1B). By constructing lanGT2 derivatives with
single and combined substitutions the importance of these
regions in influencing the C-glycosylation was investigated.
Six derivatives (lanGT2.a, lanGT2.b, lanGT2.c, lanGT2.a_b,
lanGT2.a_c, and lanGT2.a_b_c) were constructed by mega-
primer PCR. The mutant genes were cloned, verified by
sequencing, expressed, and screened for activity as stated
above. As expected from the earlier result with LanGT2.1,
region c was identified to be important for the C-glycosylating
function. The derivative LanGT2.c, carrying 10 residues from
UrdGT2, completely lost its O-glycosylating activity and instead
gained the desired C-glycosylating capability. However, the
enzyme activity was weakly active, affording only 5.9% the yield
of C-glycoside product as compared to UrdGT2. By splitting
block c into c-loop (Val51–Pro57) and c-helix (Pro57–Ile62)
a synergistic effect was observed whereby residues from both
parts were essential for C-glycosylation. Moreover, HPLC-MS
analysis revealed that LanGT2.c-loop and LanGT2.c-helix also
exhibited O-glycosylating functionality (Table S2). The residues
in region a or b slightly enhanced the C-glycosylating activity of
LanGT2.c, but the region conferring the C-C bond formation
could clearly be localized to a 10-amino acid sequence, Val52
to Ile62, located adjacent to the N3-loop region. To further
demonstrate the function of this sequence, the corresponding
10 residues in UrdGT2 were substituted with the sequence
from LanGT2 and the resulting derivative UrdGT2.c was tested
for functionality. As the crude extract of S. cyanogenus DlanGT2
x pUWL-urdGT2.c exhibited no product formation as compared
to a negative control (S. cyanogenus DlanGT2 x pUWL) this
substitution in UrdGT2 most probably led to an inactive hybrid.
As a result of the reduced C-glycosylating activity of LanGT2.c
with respect to LanGT2.h1, as well as the lack of significantChemistry & Biology 18,enhancement on substituting regions a or b, we considered
whether engineering other sites within the N-terminal 50 amino
acids would lead to an improvement. Based on the LanGT2-
UrdGT2 sequence alignment position 8 appeared to be a prom-
ising site for modification. Whereas LanGT2 has serine at this
position, UrdGT2 and the related C-GTs SaqGT5, SimB7,
Med-orf8, Hed-orf13, all of which glycosylate the phenolic ortho
carbon of similar acceptor molecules, have alanine or glycine at
this position (Figure S2). Indeed, the corresponding lanGT2
mutant LanGT2.S8A_c had improved efficiency, identical to
LanGT2.h1, affording 17% of the yield of C-glycoside product
generated by UrdGT2. A further improvement to 19% of the
UrdGT2 yield was achieved with the substitutions D30Q,
F32V, G34A, and V36N within block a. The resulting hybrid
LanGT2.S8A_a_c, with a total of 15 UrdGT2 derived substitu-
tions, was examined for further studies concerning the question
of the underlying mechanistic difference between the O- and
C-glycosylation.
Computational Docking Studies Suggest that a Modified
N5-Loop in a LanGT2-Chimera Favors C-Glycosylation
As structural data is not available for LanGT2 or UrdGT2 bound
to substrates, a computational approachwas used to identify the
sites most likely involved in substrate binding and catalysis.
Based on the crystal structure of UrdGT2 (PDB code 2P6P),
the natural glycosyl acceptor UWM6 and the glycosyl donor
TDP-D-olivose were docked onto the active site using the dock-
ing software Glide. Although this model was largely consistent
with the modeling studies from Mittler et al. (2007), we observed
one additional docking mode for UWM6. In this configuration the
C8 hydroxyl group of the acceptor and the C1-atom of the
glycosyl donor are located in close proximity (4.1 A˚) and thus
might be able to form an O-glycosidic bond. Both substrate
binding modes (1 and 2) for C- and O-glycosylation are charac-
terized by a high number of favorable molecular interactions (van
der Waals, Coulombic, and hydrophobic contacts) as expressed
by the Glide Score (1 =7.9 and 2 =8.1), although the number
of hydrogen bonds differs (three for mode 1, one for mode 2).
Based on the assumption that the LanGT2 active site will be
very similar to that calculated for UrdGT2, both docking modes
can likewise be expected, and therefore selection of amino acids
favoring O- or C-glycosylation might be possible. Using UrdGT2
as a template, structure homology models of LanGT2 were built
and, as expected, both binding modes were also observed on
docking the putative glycosyl acceptor 11-deoxy-landomyci-
none within the proposed active site. However, the binding
mode favoring O-glycosylation had the better binding energy
term as reflected by the Glide Score (6.9 versus 5.9). In
contrast, the model of LanGT2.S8A_a_c clearly agrees with the
C-glycosylating activity observed for this variant, as indicated
by the proximity of the acceptor C9 to C1 of the activated sugar
(Figure 4), as well as an improved Glide Score for this binding
mode relative to wild-type LanGT2 (Table S5). Although the
two acceptor binding modes can explain each glycosylation
outcome, the Glide Scores for each binding mode do not always
match the observed glycosylation activity of all LanGT2 variants
(Tables S1–S4 versus Table S5). This likely reflects the failure of
computational modeling to fully account for the flexibility in the
active site loops, particularly the interaction between residues520–530, April 22, 2011 ª2011 Elsevier Ltd All rights reserved 525
Figure 4. LanGT2 Modeling with a Focus on the Acceptor Posi-
tioning as the Key for O- or C-Glycosidic Bond Formation
LanGT2 modeling was based on the modeled UrdGT2 ternary complex
described in Mittler et al. (Mittler et al., 2007).
(A and B) Overlay of the ligands docked onto LanGT2 and its C-glycosylating
variant LanGT2.S8A_a_c_KES. Highlighted in lines and in surface view are
hydrophobic aminoacids involved in shaping theacceptor pocket. TheLanGT2
redocking experiments present LanGT2 favoring O-glycosylation toward
C8 hydroxyl group (shown in green), whereas the LanGT2.S8A_a_c_KES
re-docking resulted in favoring C-glycosylation onto C9 (shown in cyan). (B) A
viewof (A) rotated 90 anti-clockwise.Modes forO- andC-glycoside formation
are shown in green and cyan and are slightly angulated to each other. The
carboxylic amino acid aspartate in position 137 and the serine residue 10 are in
appropriate proximity to mediate the glycosylation reaction.
See also Table S5.
Figure 5. Relative C-Glycosylation Yields of Selected LanGT2
Derivatives
Relative yields (in triplicate) were determined by HPLC and calculated by
normalizing the peak area for the C-glycoside produced with the LanGT2
variant with the peak area of the 9-C-D-olivosyltetrangulol produced by
UrdGT2. Error bars represent the standard deviation.
See also Tables S1–S4.
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Switching the Function of the Glycosyltransferasein block c (residues 51–61) and the highly flexible loop consisting
of residues 47–76.
Optimizing C-Glycosylation Activity in LanGT2 Variants
by Rational Engineering
UrdGT2possessesfiveadditional aminoacidswhencompared to
LanGT2, three of which are in positions 223 to 225 of block 5 and
two in positions 324 and 325 of block 7. In silico analysis sug-
gested that theaminoacids 223KES225would induceanalternative
loop conformation that would help position the acceptor within
the binding pocket for C-glycosylation. To determine the func-
tional relevance of 223KES225, these residues were introduced
into wild-type LanGT2 and the C-GT variant LanGT2.S8A_a_c,526 Chemistry & Biology 18, 520–530, April 22, 2011 ª2011 Elsevieryielding LanGT2.KES and LanGT2.S8A_a_c_KES. HPLC-MS
analysis of crude extracts produced by LanGT2.KES revealed
that these additional residues did not change functionality, but
rather diminished the O-glycosylation yield to 62% of wild-type
LanGT2 (Table S2). However, variant LanGT2.S8A_a_c_KES,
derived from the C-glycosylating derivative LanGT2.S8A_a_c,
had dramatically improved activity, producing 45% of the yield
of C-glycoside obtained with the native C-GT UrdGT2 (Figure 5;
Table S2). In total, variant LanGT2.S8A_a_c_KEShas 18 substitu-
tions derived from UrdGT2. Furthermore, LanGT2 variants with
modifications in block 6 and block 7 were constructed, but
HPLC-MS analysis revealed no improvement in the C-glycosyla-
tion activity (for more details, see Supplemental Experimental
Procedures).
Features that Dictate O- or C-Glycosylation in LanGT2
The variant LanGT2.c demonstrates that a sequence of 10 amino
acids within block c is critical to convert LanGT2 from anO-GT to
a C-GT. The underlying factors are not fully understood, as the
modeled LanGT2 ternary structure shows the major part of block
c tohavenodirect ligand interactions.Nevertheless, in silicoanal-
ysis of LanGT2 bound to substrates showed Ala62 to be in close
proximity to the sugar acceptor. Interestingly, in UrdGT2 and the
other C-GTs considered above a bulkier isoleucine residue is
located at this position (Figure S2). Based onourmodeled ternary
structures we predicted that in an interplay between the residues
at positions 8 and 62 would shift the sugar acceptor toward the
appropriate location and thereby direct glycosylation at the C8
hydroxyl or C9 carbon (Figure 4). However, as shown by
HPLC-MS analysis, the substitutions S8A and A62I in LanGT2,
producing the variant LanGT2.S8A_A62I, was not sufficient
to produce C-glycosylation activity. Apparently the UrdGT2
amino acids upstream of position 62 are also necessary forLtd All rights reserved
Figure 6. A Mechanism for O- and C-Glycoside Formation Based on
Acceptor Positioning
Residues shown to be involved in the catalytic reactions were confirmed by Ala
substitutions.
(A) Shown in gray cartoon mode is the active site of the modeled ternary
structure of the C-glycosylating LanGT2 variant LanGT2.S8A_a_c_KES with
the ligands TDP-D-olivose and 11-deoxy-landomycinone after accomplished
redocking experiments. The residues Ser10, Asp137, and Ser219 identified to
be essential for catalysis are presented in stick view. Ala substitutions
performed onto residues presented in lines were shown to be nonlethal on
glycoside formation.
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Chemistry & Biology 18,C-glycosylation. This additional contribution can be calcu-
lated by substrate docking experiments onto LanGT2 and its
C-glycosylating derivatives. In the modeled LanGT2.c ternary
complex the sugar acceptor favored the UrdGT2-like position,
consistent with the weak C-glycosylation activity of this mutant.
Likewise, acceptordockingwith LanGT2.S8A_a_c_KES revealed
Glide Scores that were comparable to those observed with
UrdGT2 (Table S5). This calculation supports the superior activity
of thismutant,whichaffords45%of theproduct yield ofwild-type
UrdGT2.
Proposed Reaction Mechanisms for LanGT2
and UrdGT2
Following the assumption that LanGT2 and UrdGT2 execute
a very similar reaction mechanisms, and that the positioning of
the sugar acceptor largely determines O- or C-glycosidic sugar
attachment, there are likely similar active site residues that are
used to stabilize the glycosylation transition state. To experimen-
tally identify these critical residues we performed a series of indi-
vidual alanine substitutions in LanGT2, the C-glycosylating
variant LanGT2.S8A_a_c, and the native C-glycosylating
enzyme UrdGT2. These substitutions targeted all aspartate,
glutamate, and serine amino acids observed within a distance
of 10 A˚ around the anomeric carbon of the sugar donor as well
as C8 and C9 of the acceptor molecules. Selection of these sites
was assisted by the modeled LanGT2 and UrdGT2 ternary
complexes, leading to a total of 26 point mutations (Tables S3
and S4). As shown by HPLC-MS analysis, the activity of all three
enzymes was abolished with the substitutions S10A, D137A, or
S219A, indicating that these residues are critical for enzyme
folding and/or catalysis. For all other mutants the Ala substitution
resulted in reduced glycosylation yields (Tables S3 and S4).
As previously proposed in Mittler et al. (2007) for UrdGT2,
Asp137 likely serves as a general base by stabilizing develop-
ment of a phenolate ion and thereby increase the carbanionic
character of the ortho carbon (C9) through resonance. This
would increase the reactivity of the acceptor in a Friedel-Crafts
like reaction with the sugar donor. Likewise, models of the C-gly-
cosylating variants of LanGT2 (Figure 4B) reveal the carboxylate
group of Asp137 to be within hydrogen bonding distance of the
phenolic (C8) hydroxyl of the acceptor. The importance of this
residue for activity suggests a similar role for Asp137 as a general
base. Indeed, the models indicate that no other residue is appro-
priately positioned to fulfill this critical role (Figure 6). Interest-
ingly, the role of Asp137 in wild-type LanGT2 may be slightly
different due to the position of the acceptor in the active site.
As shown in Figure 6C, the distance between the carboxylate(B) Overlay of the two positioning modes of 11-deoxy-landomycinone favoring
O- and C-glycosylation, respectively. Active site residues Asp137 and Ser10
are shown as sticks. The mode favoring O-glycosylation toward C8 hydroxyl
group is presented in green colored stick view. The acceptor mode favoring
glycosylation of C9 is colored in cyan. The glycosylation site of each enzyme is
highlighted with an arrow.
(C) Mechanism of LanGT2 catalyzed O-glycosylation of 11-deoxy-land-
omycinone with TDP-D-olivose illustrating the proposed roles of Asp137 and
Ser10. A water molecule is thought to mediate proton transfer to Asp137.
(D) Mechanism for C-glycosylation of C9 of 11-deoxy-landomycinone (see text
for details).
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proton transfer during general base catalysis. Nevertheless,
transfer of a proton through a water molecule or slight shifting
of the Asp137 side chain to within hydrogen bonding distance
of the acceptor may allow this residue to fulfill this role.
The reaction with the glycosyl donor most likely follows the
typical SN2 mechanism as often described for inverting GTs.
As illustrated in Figure 4 and Figure 6, the active site residue
Ser10 in UrdGT2 and LanGT2 is in close proximity to the
acceptor nucleophilic atoms. As this residue is within hydrogen
bonding distance of the acceptor C8 hydroxyl group (in LanGT2)
and C9 carbon (in UrdGT2 and C-glycosylating LanGT2 vari-
ants), Ser10 possibly serves to stabilize the increase in electron
density expected at these positions in the transition state. After
acceptor activation the anomeric carbon of sugar donor is
attacked to form the glycosidic bond, which is assisted by the
good leaving group properties of the nucleoside diphosphate.
As revealed by the modeled C-glycosylating LanGT2 ternary
complex (Figure 6A), the dramatic effect of the S219A substitu-
tion is most likely due to a disrupted interaction with the sugar-
donor. As shown in the sequence alignment (Figure S1) this
site is highly conserved within GTs. The modeled ternary
complex shows Ser219 to be within hydrogen bonding distance
of the oxygen of the sugar nucleotide phosphate (Figure 6A).
Clearly this interaction is essential for catalysis, possibly in stabi-
lizing charge development on the phosphate oxygen in the
transition state. The proximity of the basic residue Lys225 in
LanGT2 (Arg228 in UrdGT2) to the phosphatesmight additionally
stabilize such charge development (Figure 6A).
DISCUSSION
Microorganisms produce a plethora of natural products that hold
great promise for use as therapeutic agents. But before clinical
applications are feasible, properties influencing the pharmaco-
logical or pharmacokinetic qualities of a molecule often need
to be improved. This can be achieved by adding or deleting func-
tional groups on the molecule through synthetic or enzyme
based chemistry. However, the application of conventional
chemistry is often thwarted by the stereochemical and functional
group complexity of natural products, which typically demand
multiple reaction steps to achieve one simple modification.
Although enzymes in theory offer a solution to this problem,
the inherently high specificity of most enzymes involved in
natural product biosynthesis restricts their use in generating
modified molecules. To circumvent this limitation, enzymes
may be evolved or rationally engineered to create a variant that
performs the desired biocatalytic reaction. In this article we
present the engineering process to convert an O-glycosylating
transferase to a C-glycosylating enzyme. To the best of our
knowledge, the rational transformation of an O-GT toward
a C-GT has not been documented before. To circumvent the
considerable challenge of synthesizing the required NDP-deoxy
sugar donor and acceptors for assaying LanGT2 variants, func-
tional screening in this studywas performed in vivo. Likewise, the
use of computational design reduced the number of potential
mutants to a manageable number. Visualized by modeled
ternary structures we could show that the architecture of the
LanGT2 acceptor-binding sites primarily determines the528 Chemistry & Biology 18, 520–530, April 22, 2011 ª2011 Elsevieroutcome of O- versus C-glycosylation. Furthermore, we were
able to propose the underlying catalytic mechanisms, which in
both reactions is driven by identical amino acids located in
similar positions. The mechanism follows an SN2 like reaction
where Asp137 in LanGT2 (Asp137 in UrdGT2) is the general
base that increases the phenolic character in C8 hydroxyl
group. This increases the nucleophilicity of the C8 hydroxyl
group, and through resonance likewise increases the nucleo-
philic character of the ortho carbon (C9) of the acceptor.
However, the C8 hydroxyl is expected to be the more reactive
site as reaction at C9 transiently destroys aromaticity. This is
most simply illustrated by preference for O-alkylation of phenol
in all solvents except those that strongly hydrogen bond to the
hydroxyl group (Carey and Sundberg, 2007). Therefore GT
catalyzed O-glycosylation and C-glycosylation is ultimately
dependent on positioning the C8 hydroxyl or the C9 carbon of
the acceptor relative to anomeric carbon of the glycosyl donor,
as opposed to the relative nucleophilicities of the two sites.
Interestingly, none of the LanGT2 variants produced a mixture
of O- and C-glycosides. This supports the hypothesis that GT
catalyzed C-glycosylation follows the direct Friedel-Crafts alkyl-
ation mechanism and excludes the possibility of an underlying
O- to C-rearrangement. The success in converting LanGT2 to
a strictly C-glycosylating enzyme can be attributed to replacing
block C of LanGT2 with the analogous sites from UrdGT2.
A model of this LanGT2 variant complexed with the glycosyl
donor and acceptor predicts that these 10 amino acid substitu-
tions collectively position the acceptor for C-glycosylation.
Residues at positions 8 and 62 are the most crucial as they
appear to have the most influence over glycosylation of the C8
hydroxyl or the C9 carbon. However, in the absence of an
LanGT2 X-ray crystal structure, postulating an exact reason for
the observed switch in regioselectivity is not possible, especially
because block c is comprised of ‘‘second sphere’’ residues that
do not directly interact with the substrates. Likewise, it is unclear
why LanGT2.c and LanGT2.1, which differ only in positions 51
and 64, produce such dramatically different C-glycoside yields.
Presumably the valine or leucine in position 51 is not as critical
as the residue in position 64, because in LanGT2.c position 64
is occupied by threonine with a hydroxyl group available to
form a hydrogen bond, whereas LanGT2.1 cannot do so as
this position is occupied by methionine.
After succeeding in this O-GT to C-GT transformation the
question arises if this engineering process can be adopted to
other GTs. Some of the issues faced in aryl-C-bond chemistry
have been summarized by Bililign et al. (2005). In particular,
aryl C-glycosylation likely requires electron rich aromatic
systems, such as those bearing hydroxyl, methoxy, or amine
substituents, of which there are many examples. Our results
suggest that glycosylation can be directed to the electron rich
ortho and para positions by adjusting the position of the acceptor
in the GT active site. Accordingly, further potential applications
for engineering might be the conversion of the antipsoriatic
agents anthralin and its 1,2 dihydroxy derivative into the corre-
sponding 2-C- and 2-O-glycosides, which could reduce their
inflammatory side effects. Our work suggests that even in the
absenceof a experimentally determined structural data, a combi-
nation of homology modeling and sequence analysis can be
successfully applied to solving such engineering problems.Ltd All rights reserved
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Based on the C-glycosylating enzyme UrdGT2 we generated
a structural LanGT2 model, followed by computational dock-
ing of substrates in the predicted LanGT2 active site. By
comparing these predicted structural features with UrdGT2
and other C-glycosylating enzymes, 106 variants of LanGT2
were iteratively generated and tested for C-glycosylating
activity. In addition to generating a highly active C-glycosylat-
ing variant of LanGT2, we have also gained considerable
insight into the mechanistic features that control O- and
C-glycosidic bond formation. A very notable feature of this
effort is that the screening of C- versus O-glycosylating
activity was conducted in vivowithin the context of a complex
biosynthetic pathway, which we believe is a timely contribu-
tion to the rapidly emerging field of combinatorial biosyn-
thesis. Due to the difficulty in chemically synthesizing
C-glycosides, as well as the potential of these compounds in
drugdevelopment, enzymes involved tocatalyzeC-glycosidic
bonds are a promising alternative to conventional chemistry.
EXPERIMENTAL PROCEDURES
Construction of lanGT2-urdGT2 Chimeric Genes
As described previously the wild-type genes lanGT2 and urdGT2 were cloned
into the HindIII and XbaI sites of pMun2 (Trefzer et al., 2000, 2001). In general,
for generating the lanGT2-urdGT2 chimeras lanGT2.h1 to lanGT2.h12 we
made use of the gene flanking sites HindIII and XbaI as well as the restriction
sites NcoI, SnaBI, BsrGI, BsiWI within lanGT2 and urdGT2. PCR was used to
incorporate silent mutations encoding the restriction sites NcoI, SnaBI, and
BsiWI at positions matching the lanGT2 sequence. The required PCR primers
are listed in Supplemental Experimental Procedures.
Generating lanGT2-urdGT2 Hybrids and Alanine Substitutions
by the PCR Megaprimer Method
In general the constructswere generated as described previously (Krauth et al.,
2009). The applied protocol as well as the primers are listed in Supplemental
Experimental Procedures.
Genetic Manipulation of S. Cyanogenus DlanGT2
Before transforming the mutant with the LanGT2-UrdGT2 hybrides encoded
on pUWL (Doumith et al., 2000) expression vector, they were passed through
E. coli ET 12567 cells (Flett et al., 1997) to obtain unmethylated DNA. The
conjugation of Streptomyces strains as well as growth conditions are
described in Supplemental Experimental Procedures.
Functionality Screening
Exconjugants were cultured for 72 hr in 100 ml baffled flasks (250 rpm, 28C),
each containing 20 ml SG medium (1% w/v soybean meal, 2% glucose,
0.2% CaCO3, 0.2% valine) supplemented with hygromycin (50 mg/ml), specti-
nomycin (50 mg/ml), and phosphomycin (200 mg/ml). Landomycins and tetran-
gulol derivatives were extracted from liquid cultures with 1 volume of ethyl
acetate. The O- and C-glycosides products were analyzed on a Agilent 1100
HPLC-ESI-MS system (Agilent Technologies, Waldbronn, Germany) equipped
withUV-visible and a single quadrupole detector. HPLC separationwas carried
out on a Zorbax XDB-C8 column (5 mm, 4.6 3 150 mm) with a Zorbax SB-C8
precolumn (5mm,4.6312.5mm) fromAgilent Technologies.Samplesweredis-
solved in MeOH and resolved at flow rate of 0.7 ml/min with the following step
gradient: 0–9min30%B,9–16min35%B,16–19min60%B,19–23min85%B,
23–26 min 95%B (solvent A: 99.5%water, 0.5% acetic acid; solvent B: aceto-
nitrile). TheUVdetectionwavelengthwas 254nm. ESI-MS (negativemode)was
carried out using the following settings: drying gas flow, 12 ml/min; drying gas
temperature, 350C; nebulizer pressure, 50 psig; capillary voltage, 3000 V,
mass range set to: 300–1150 Da. Fragmentation analysis of O- and C-glyco-Chemistry & Biology 18,sidic linkages was performed on an Agilent 1100 HPLC-ESI-MS/MS system
equipped with UV-visible and a triple quadrupole detector. Analysis was per-
formed in negative ion mode with a mass range from 100 to 600 m/z. Samples
were resolved on a LiChrodphor 100RP 18 column (5 mm particle size, 2 3
125 mm) at 0.3 ml/min with the following step gradient: 0–5 min 0% B,
5–20 min 100% B, 20–25 min 100% B, 25–27 min 0% B, 27–35 min 0% B
(solvent A: 99.5% water, 0.5% acetic acid; solvent B: acetonitrile).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and five tables and can be found with this article online at
doi:10.1016/j.chembiol.2011.02.013.
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